Purple Biotech Ltd. · TASE:PPBT
Mitchell P. Kopin reported a 9.99% stake in Purple Biotech Ltd. (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 13, 2026
Mitchell P. Kopin reported a 9.99% stake in Purple Biotech Ltd., 282,513,535 shares, as a passive investor on Mar 31, 2026. Filed May 13, 2026 (Schedule 13G/A).
- Stake
- 9.99%
- Shares
- 282,513,535
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Mitchell P. Kopin | 9.99% | 282,513,535 |
| Daniel B. Asher | 9.99% | 282,513,535 |
| Intracoastal Capital LLC | 9.99% | 282,513,535 |
Source
Related
- Purple Biotech Ltd.
- Mitchell P. Kopin
- Purple Biotech Ltd. shareholders
- Schedule 13G/A · Mitchell P. Kopin · Nov 7, 2025
- Schedule 13G · Mitchell P. Kopin · Sep 10, 2025
- Schedule 13G/A · G1 Execution Services, LLC · Aug 14, 2026
- Schedule 13G · G1 Execution Services, LLC · Feb 13, 2026
- Schedule 13G · Orca Capital AG · Sep 9, 2025
- Schedule 13G/A · Orca Capital AG · Sep 9, 2025
- Schedule 13G · Lincoln Alternative Strategies LLC · Sep 9, 2025